Quantum leaps in aging research: an interview with Peter Fedichev

In this interview we speak with Peter Fedichev (Gero; CA, USA) about AI-driven drug discovery in aging research. Peter explains more about the use of quantum computing in drug design, and how Gero's recent research has contributed to human age-related diseases research. What exactly is quantum computing and how can it be applied to drug design? Could you give a summary of Gero's recently published research paper? Many companies have applied AI to drug discovery and design, how is Gero's approach unique? How do you anticipate quantum computing in drug design to evolve in the future? Disclaimers: The opinions expressed...